Related references
Note: Only part of the references are listed.The induction of innate and adaptive immunity by biodegradable poly(γ-glutamic acid) nanoparticles via a TLR4 and MyD88 signaling pathway
Tomofumi Uto et al.
BIOMATERIALS (2011)
N,N′-Carbonyldiimidazole-mediated functionalization of superparamagnetic nanoparticles as vaccine carrier
Jenny Ho et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2011)
Altered Expressions of Helper T Cell (Th)1, Th2, and Th17 Cytokines in CD8+ and γδ T Cells in Patients with Allergic Asthma
Yang Zhao et al.
JOURNAL OF ASTHMA (2011)
Induction of humoral immune response against PfMSP-119 and PvMSP-119 using gold nanoparticles along with alum
Shaheena Parween et al.
VACCINE (2011)
Pharmaceutical and immunological evaluation of mucoadhesive nanoparticles based delivery system(s) administered intranasally
Sharad Mangal et al.
VACCINE (2011)
Poly(methyl vinyl ether-co-maleic anhydride) nanoparticles as innate immune system activators
A. I. Camacho et al.
VACCINE (2011)
Nanomedicine: Novel approaches in human and veterinary therapeutics
Juan M. Irache et al.
VETERINARY PARASITOLOGY (2011)
Silent mysteries: epigenetic paradigms could hold the key to conquering the epidemic of allergy and immune disease
D. J. Martino et al.
ALLERGY (2010)
Surveillance of systemic reactions to subcutaneous immunotherapy injections: year 1 outcomes of the ACAAI and AAAAI Collaborative Study
David I. Bernstein et al.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2010)
Novel immunotherapeutic approaches for allergy and asthma
Liam O'Mahony et al.
AUTOIMMUNITY (2010)
CpG Oligodeoxynucleotides as TLR9 Agonists Therapeutic Application in Allergy and Asthma
Gaurav K. Gupta et al.
BIODRUGS (2010)
Chitosan Nanoparticles: A Promising System in Novel Drug Delivery
Kalpana Nagpal et al.
CHEMICAL & PHARMACEUTICAL BULLETIN (2010)
Poly(Anhydride) Nanoparticles Act as Active Th1 Adjuvants through Toll-Like Receptor Exploitation
I. Tamayo et al.
CLINICAL AND VACCINE IMMUNOLOGY (2010)
Biodegradable polymeric nanoparticles based drug delivery systems
Avnesh Kumari et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2010)
The current state of recombinant allergens for immunotherapy
Gabrielle Pauli et al.
CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY (2010)
Minireview: Nanoparticles and the Immune System
Banu S. Zolnik et al.
ENDOCRINOLOGY (2010)
Role of Treg in immune regulation of allergic diseases
Oscar Palomares et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2010)
Influence of reaction medium during synthesis of Gantrez® AN 119 nanoparticles for oral vaccination
Katrien Vandamme et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2010)
Chitosan as a carrier for targeted delivery of small interfering RNA
Walter E. Rudzinski et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2010)
Allergen immunotherapy
Anthony J. Frew
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2010)
Delivery of a peptide via poly(D,L-lactic-co-glycolic) acid nanoparticles enhances its dendritic cell-stimulatory capacity
Corbin Clawson et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2010)
Nanotechnology-based manipulation of dendritic cells for enhanced immunotherapy strategies
Rebecca Klippstein et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2010)
Immunomodulatory nanoparticles as adjuvants and allergen-delivery system to human dendritic cells: Implications for specific immunotherapy
Sissela Broos et al.
VACCINE (2010)
Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy
Parag Aggarwal et al.
ADVANCED DRUG DELIVERY REVIEWS (2009)
Nanoparticles for nasal vaccination
Noemi Csaba et al.
ADVANCED DRUG DELIVERY REVIEWS (2009)
Sub-lingual Immunotherapy: World Allergy Organization Position Paper 2009
ALLERGY (2009)
New insights into the mechanism and management of allergic diseases: atopic dermatitis
N. Novak
ALLERGY (2009)
The enhancement of the immune response against S. equi antigens through the intranasal administration of poly-ε-caprolactone-based nanoparticles
H. F. Florindo et al.
BIOMATERIALS (2009)
The immunologic effect of TGF-beta1 chitosan nanoparticle plasmids on ovalbumin-induced allergic BALB/c mice
Fei Li et al.
IMMUNOBIOLOGY (2009)
Mechanisms and treatment of allergic disease in the big picture of regulatory T cells
Cezmi A. Akdis et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2009)
A novel nanoparticulate adjuvant for immunotherapy with Lolium perenne
Sara Gomez et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2009)
Chitosan Micro- and Nanospheres: Fabrication and Applications for Drug and DNA Delivery
Andrea Masotti et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2009)
Therapeutic manipulation of immune tolerance in allergic disease
Muebeccel Akdis et al.
NATURE REVIEWS DRUG DISCOVERY (2009)
Allergen-related approaches to immunotherapy
Jennifer M. Rolland et al.
PHARMACOLOGY & THERAPEUTICS (2009)
An immunological overview of allergen specific immunotherapy — subcutaneous and sublingual routes
Cevdet Ozdemir
Therapeutic Advances in Respiratory Disease (2009)
Nanotechnology in vaccine delivery
Laura J. Peek et al.
ADVANCED DRUG DELIVERY REVIEWS (2008)
The genetic and environmental basis of atopic diseases
Alexandros P. Grammatikos
ANNALS OF MEDICINE (2008)
Particle-based vaccines for transcutaneous vaccination
Behazine Combadiere et al.
COMPARATIVE IMMUNOLOGY MICROBIOLOGY AND INFECTIOUS DISEASES (2008)
Alginate coated chitosan nanoparticles are an effective subcutaneous adjuvant for hepatitis B surface antigen
Olga Borges et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2008)
Immunomodulatory biomaterials
Surya K. Mallapragada et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2008)
Vaccine adjuvant systems: Enhancing the efficacy of sub-unit protein antigens
Yvonne Perrie et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2008)
Nano/micro technologies for delivering macromolecular therapeutics using poly(D,L-lactide-co-glycolide) and its derivatives
Raghavendra C. Mundargi et al.
JOURNAL OF CONTROLLED RELEASE (2008)
Preclinical studies to understand nanoparticle interaction with the immune system and its potential effects on nanoparticle biodistribution
Marina A. Dobrovolskaia et al.
MOLECULAR PHARMACEUTICS (2008)
Novel nanoparticles for the delivery of recombinant hepatitis B vaccine
Dhruba J. Bharali et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2008)
Discovering susceptibility genes for asthma and allergy
Donata Vercelli
NATURE REVIEWS IMMUNOLOGY (2008)
Evaluation of the immune response following a short oral vaccination schedule with hepatitis B antigen encapsulated into alginate-coated chitosan nanoparticles
Olga Borges et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2007)
Novel recombinant interleukin-13 peptide-based vaccine reduces airway allergic inflammatory responses in mice
Yanbing Ma et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2007)
Immunological properties of engineered nanomaterials
Marina A. Dobrovolskaia et al.
NATURE NANOTECHNOLOGY (2007)
Gantrez® AN nanoparticles as an adjuvant for oral immunotherapy with allergens
Sara Gomez et al.
VACCINE (2007)
Increased frequency of large local reactions among systemic reactors during subcutaneous allergen immunotherapy
Sitesh R. Roy et al.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2007)
Polymorphisms in IL13, total IgE, eosinophilia, and asthma exacerbations in childhood
Gary M. Hunninghake et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2007)
Novel cytokine peptide-based vaccines: an interleukin-4 vaccine suppresses airway allergic responses in mice
Y. Ma et al.
ALLERGY (2007)
Protective immunity of biodegradable nanoparticle-based vaccine against an experimental challenge with Salmonella Enteritidis in mice
Javier Ochoa et al.
VACCINE (2007)
Sulfated chitin and chitosan as novel biomaterials
R. Jayakumar et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2007)
Chitosan-graft-polyethylenimine as a gene carrier
Hu-Lin Jiang et al.
JOURNAL OF CONTROLLED RELEASE (2007)
Synthesis and characterization of PEG modified N-trimethylaminoethylmethacrylate chitosan nanoparticles
Siyu Zhu et al.
EUROPEAN POLYMER JOURNAL (2007)
Peanut allergy: Emerging concepts and approaches for an apparent epidemic
Scott H. Sicherer et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2007)
Nanoparticles as potential oral delivery systems of proteins and vaccines: A mechanistic approach
Anne des Rieux et al.
JOURNAL OF CONTROLLED RELEASE (2006)
Immunological mechanisms of allergen-specific immunotherapy
Mark Larche et al.
NATURE REVIEWS IMMUNOLOGY (2006)
Development of a novel vaccine delivery system based on Gantrez nanoparticles
Sara Gomez et al.
JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY (2006)
Particulate delivery systems for vaccines: what can we expect?
Vincent W. Bramwell et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2006)
Biodegradable PLGA particles for improved systemic and mucosal treatment of type I allergy
Isabella Schoell et al.
IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA (2006)
IgG-blocking antibodies inhibit IgE-mediated anaphylaxis in vivo through both antigen interception and FcγRIIb cross-linking
RT Strait et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Molecular approaches for new vaccines against allergy
Verena Niederberger et al.
EXPERT REVIEW OF VACCINES (2006)
Chitosan nanoparticles for oral drug and gene delivery
Katherine Bowman et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2006)
Allergy practice worldwide: A report by the World Allergy Organization Specialty and Training Council
JO Warner et al.
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (2006)
Methods for nano-particle based vaccine formulation and evaluation of their immunogenicity
Martha Kalkanidis et al.
METHODS (2006)
In vivo targeting of dendritic cells for activation of cellular immunity using vaccine carriers based on pH-responsive microparticles
YJ Kwon et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Preparation and characterization of biodegradable nanoparticles based on poly(γ-glutamic acid) with L-phenylalanine as a protein carrier
T Akagi et al.
JOURNAL OF CONTROLLED RELEASE (2005)
Salmonella-like bioadhesive nanoparticles
HH Salman et al.
JOURNAL OF CONTROLLED RELEASE (2005)
Preparation of coated nanoparticles for a new mucosal vaccine delivery system
O Borges et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2005)
Enhanced antigen presentation and immunostimulation of dendritic cells using acid-degradable cationic nanoparticles
YJ Kwon et al.
JOURNAL OF CONTROLLED RELEASE (2005)
Review of novel particulate antigen delivery systems with special focus on treatment of type I allergy
I Schöll et al.
JOURNAL OF CONTROLLED RELEASE (2005)
PLA-PEG particles as nasal protein carriers:: the influence of the particle size
A Vila et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2005)
Enhancement of T helper type 1 immune responses against hepatitis B virus core antigen by PLGA nanoparticle vaccine delivery
CSW Chong et al.
JOURNAL OF CONTROLLED RELEASE (2005)
Formulation aspects of biodegradable polymeric microspheres for antigen delivery
H Tamber et al.
ADVANCED DRUG DELIVERY REVIEWS (2005)
Immunologic influences on allergy and theTH1/TH2 balance
S Romagnani
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2004)
Associations between specific serum IgE response and 6 variants within the genes IL4, IL13, and IL4RA in German children:: The German Multicenter Atopy Study
X Liu et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2004)
Amb a 1-immunostimulatory oligodeoxynucleotide conjugate immunotherapy decreases the nasal inflammatory response
MK Tulic et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2004)
Allergen-loaded biodegradable poly(D,L-lactic-co-glycolic) acid nanoparticles down-regulate an ongoing Th2 response in the BALB/c mouse model
I Schöll et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2004)
Size-dependent immunogenicity: Therapeutic and protective properties of nano-vaccines against tumors
T Fifis et al.
JOURNAL OF IMMUNOLOGY (2004)
Transport of PLA-PEG particles across the nasal mucosa: effect of particle size and PEG coating density
A Vila et al.
JOURNAL OF CONTROLLED RELEASE (2004)
Adjuvants for allergen immunotherapy: experimental results and clinical perspectives
James N. Francis et al.
CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY (2004)
Recent advances on chitosan-based micro- and nanoparticles in drug delivery
SA Agnihotri et al.
JOURNAL OF CONTROLLED RELEASE (2004)
Poly-ε-caprolactone microspheres and nanospheres:: an overview
VR Sinha et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2004)
Molecular mechanisms in allergy and clinical immunology
SJ Till et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2004)
Low molecular weight chitosan nanoparticles as new carriers for nasal vaccine delivery in mice
A Vila et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2004)
Influence of the surface characteristics of PVM/MA nanoparticles on their bioadhesive properties
P Arbós et al.
JOURNAL OF CONTROLLED RELEASE (2003)
Noninjection routes for immunotherapy
GW Canonica et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2003)
Analysis of the role of vaccine adjuvants in modulating dendritic cell activation and antigen presentation in vitro
HF Sun et al.
VACCINE (2003)
Accelerated immune response to DNA vaccines
L Zhang et al.
DNA AND CELL BIOLOGY (2003)
From allergen structure to new forms of allergen-specific immunotherapy
R Valenta et al.
CURRENT OPINION IN IMMUNOLOGY (2002)
Immunization by particle-mediated transfer of the granulocyte-macrophage colony-stimulating factor gene into autologous tumor cells in melanoma or sarcoma patients: Report of a phase I/IB study
DM Mahvi et al.
HUMAN GENE THERAPY (2002)
Quantification of the bioadhesive properties of protein-coated PVM/MA nanoparticles
P Arbós et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2002)
Biodegradable nanoparticles for drug delivery and targeting
ML Hans et al.
CURRENT OPINION IN SOLID STATE & MATERIALS SCIENCE (2002)
Polyester microparticles as a vaccine delivery system for brucellosis:: Influence of the polymer on release, phagocytosis and toxicity
M Murillo et al.
JOURNAL OF DRUG TARGETING (2002)
Design of biodegradable particles for protein delivery
A Vila et al.
JOURNAL OF CONTROLLED RELEASE (2002)
Biodegradable poly (DL-lactide glycolide) microparticles as a vehicle for allergen-specific vaccines: a study performed with Ole e 1, the main allergen of olive pollen
E Batanero et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2002)
Chitosans for gene delivery
G Borchard
ADVANCED DRUG DELIVERY REVIEWS (2001)
Chitosan for mucosal vaccination
IM van der Lubben et al.
ADVANCED DRUG DELIVERY REVIEWS (2001)
Chitosan as a novel nasal delivery system for vaccines
L Illum et al.
ADVANCED DRUG DELIVERY REVIEWS (2001)
Biodegradable polymeric nanoparticles as drug delivery devices
KS Soppimath et al.
JOURNAL OF CONTROLLED RELEASE (2001)
Biodegradable microparticles with different release profiles: Effect on the immune response after a single administration via intranasal and intramuscular routes
ID Spiers et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2000)
Conjugation of immunostimulatory DNA to the short ragweed allergen Amb a 1 enhances its immunogenicity and reduces its allergenicity
H Tighe et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2000)
Revisiting PLA/PLGA microspheres: an analysis of their potential in parenteral vaccination
P Johansen et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2000)
The adjuvant monophosphoryl lipid A increases the function of antigen-presenting cells
G De Becker et al.
INTERNATIONAL IMMUNOLOGY (2000)
Variation in the interleukin 4-receptor α gene confers susceptibility to asthma and atopy in ethnically diverse populations
C Ober et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2000)
Th-2 cytokines in allergic disease
DS Robinson
BRITISH MEDICAL BULLETIN (2000)
Share Paper
